Lv4
420 积分 2024-08-28 加入
Efficacy and Safety of Second‐Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID
1个月前
已关闭
Updating the potentially inappropriate medication (PIM)-China criteria for 2024: a Delphi consensus study for improved medication safety in older adults
8个月前
已完结
欧洲老年人潜在不适当处方筛查/处方遗漏筛查工具解读
8个月前
已完结
皖公网安备34019202002308
